<DOC>
	<DOC>NCT00879346</DOC>
	<brief_summary>Phase I, randomised, open label, 3-period crossover study in healthy male subjects to investigate the effect of food on the pharmacokinetics of AZD8931 and to investigate the safety and tolerability of AZD8931.</brief_summary>
	<brief_title>A Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 Tablets</brief_title>
	<detailed_description />
	<criteria>Provision of written informed consent Body mass index (BMI) between 19 and 30 kg/m2 Use of any prescribed or nonprescribed medication (including analgesics, herbal remedies, vitamins and minerals) during the two weeks prior to the first administration of investigational product Administration of another investigational medicinal product in the 3 months before the start of dosing in this study Definite or suspected clinically relevant personal history of adverse drug reactions, or drug hypersensitivity</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>ADME</keyword>
	<keyword>Healthy male volunteers</keyword>
</DOC>